Rayner opens Ridley Innovation Centre
TBC Soosan Jacob
Published: Monday, April 11, 2016
Rayner has officially opened The Ridley Innovation Centre, a new £20million R&D, training and production facility in Worthing, West Sussex. The state of the art, dedicated intraocular lens (IOL) production facility has the capability of manufacturing three million intraocular lenses each year. In addition, a new Enterprise Resource Planning (ERP) quality system enables the company to trace every lens from source materials to a patient’s eye.
“The opening of The Ridley Innovation Centre marks a significant step in what we plan to be an exciting, transformative period of growth ahead of Rayner. This major investment will treble our manufacturing capacity and put us in the best position to support the company’s ambitious business expansion, ” said Tim Clover, CEO, Rayner.
The new centre has also been designed to enable training, education and research. Featuring a wet lab, library, training facilities and a museum on the history of the IOL, Rayner also plans to engage and partner surgeons and academics in new product development with a product pipeline of 11 new products in three years.
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.